Veltassa

— THERAPEUTIC DISORDERS TREATED —
  • Electrolyte disturbances

Veltassa Generic Name & Formulations

General Description

Patiromer 8.4g, 16.8g, 25.2g; per pkt; pwd for oral susp.

Pharmacological Class

Potassium binder.

How Supplied

Single-use packets (8.4g)—4, 30; (16.8g, 25.2g)—30

Manufacturer

Generic Availability

NO

Veltassa Indications

Indications

Hyperkalemia.

Limitations of Use

Not for emergency treatment for life-threatening hyperkalemia due to its delayed onset of action.

Veltassa Dosage and Administration

Adult

Give at least 3hrs before or 3hrs after other oral medications. Take without regard to food; mix with water. Initially 8.4g once daily. Adjust dose in 8.4g increments as needed at ≥1-week intervals to obtain desired serum potassium target range; max 25.2g/day.

Children

Not established.

Veltassa Contraindications

Not Applicable

Veltassa Boxed Warnings

Boxed Warning

Binding to other oral medications.

Veltassa Warnings/Precautions

Warnings/Precautions

Avoid in severe constipation, bowel obstruction or impaction, abnormal post-op bowel motility disorders. Monitor serum potassium, magnesium. Consider magnesium supplementation if low serum levels develop.

Veltassa Pharmacokinetics

See Literature

Veltassa Interactions

Interactions

May reduce absorption and efficacy of other oral medications; separate dosing by at least 3hrs.

Veltassa Adverse Reactions

Adverse Reactions

Constipation, hypomagnesemia, diarrhea, nausea, abdominal discomfort, flatulence.

Veltassa Clinical Trials

See Literature

Veltassa Note

Not Applicable

Veltassa Patient Counseling

See Literature

Images